Related Experiment Videos
Breast cancer risk for women with a false positive screening test
P H Peeters1, M Mravunac, J H Hendriks
1Department of Epidemiology, Institute for Social Medicine, Nijmegen, The Netherlands.
British Journal of Cancer
|August 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.
International journal of cancer·2018
A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.
International journal of cancer·2016
Particulate matter air pollution components and risk for lung cancer.
Environment international·2015
The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors.
Breast cancer research and treatment·2015
Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.
British journal of cancer·2026
Radiomics as a spatial context for treatment decision-making in head and neck cancer.
British journal of cancer·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026